Israel’s Teva donating potential COVID-19 treatment to US hospitals
Teva Pharmaceuticals to donate 6 million hydroxychloroquine tablets through wholesalers to hospitals by March 31, and 10 million within a month.
Teva Pharmaceuticals to donate 6 million hydroxychloroquine tablets through wholesalers to hospitals by March 31, and 10 million within a month.
From devices to pharmaceuticals, Israeli approaches offer hope to the millions of migraine sufferers worldwide.
End-of-year IVC-Meitar market report shows 93 merger & acquisition deals, 8 buyouts and 3 IPOs.
Pocket-sized medical plants inhalation device is the world’s first to meet pharmaceutical standards.
Mega acquisition by Israeli company comes one day after final purchase of Allergan’s generic medicines producer, Actavis Generics.
Teva Pharmaceuticals makes history with $40.5b deal; Allergan purchase is the largest-ever acquisition by an Israeli company.
FutuRx, a partnership between OrbiMed, J&J and Takeda Ventures, is one of three new government-backed, high-risk pharma incubators in Israel.
Eric Sirkin says there is no reason Israeli companies can’t be large and multinational. It just requires a shift of mentality, he says.
The companies will research and develop drugs that ‘build on our understanding of how cells repair DNA damage.’
Against the backdrop of tensions in the south, four Gazan children are getting lifesaving treatment at Rambam Medical Center in Haifa.